Latest Revenue Growth News

Beforepay Group Limited reported a record Q4 FY25 with a 76% increase in net profit before tax, driven by strong revenue growth and strategic U.S. partnerships through Carrington Labs.

ikeGPS reports a robust 29% increase in annual platform subscription revenue exit run rate for 1Q FY26, reiterating strong FY26 growth guidance and securing A$18 million in fresh capital to fuel expansion and new product development.

Epsilon Healthcare has emerged from voluntary administration with a stronger balance sheet, securing refinancing and preparing to launch its new pharmacy platform. Operational stability and strategic initiatives signal a turning point for the healthcare group.

Bubs Australia Limited reports a strong FY25 with 29% revenue growth to $102.5 million, positive EBITDA turnaround, and sustained cash flow improvements. The company also advances its US market ambitions with a key FDA submission underway.

Beam Communications reported a modest adjusted cash outflow in Q4 FY25 despite a 36% revenue drop due to delivery delays and sales transitions, while cost-cutting efforts continue to bolster its financial resilience.

Adrad Holdings has appointed Paul Proctor as interim CEO following Kevin Boyle's resignation, while maintaining a steady earnings forecast for FY25.

333D Limited reported a 12% increase in quarterly cash receipts from digital asset management contracts, maintaining steady cash flow despite slight operating cash usage. The company’s annual contract revenue surpassed $970,000, reflecting growing traction in healthcare digital services.

Pureprofile Limited reported record FY25 results, achieving 19% revenue growth and launching new AI-driven data solutions to fuel future expansion.

Pureprofile has reported record FY25 results, with revenue climbing 19% and EBITDA up 18%, driven by strong international growth and innovative AI platform launches.

Central Petroleum Limited reports a robust 22% increase in full-year revenue for FY25, driven by new gas sale contracts and strong operational cash flows. Production at key fields remains steady despite temporary constraints.

ECS Botanics reports a 20% quarterly surge in direct-to-consumer sales and a record medicinal cannabis harvest, supported by an expanded loan facility to fuel further growth.

FINEOS Corporation Holdings PLC reports steady revenue growth and operational efficiencies in Q2 2025, alongside new client contracts in North America that bolster its outlook for positive free cash flow this fiscal year.